New

Europe Leukapheresis Market

2021

Europe Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)

Publication Month: Nov 2021 | Report Code: TIPRE00025790 | No. of Pages: 132 | Category: Pharmaceuticals | Status: Published

Market Insights

Europe Leukapheresis Market to Grow at a CAGR of 8.2% to reach US$ 39.26 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The leukapheresis market in Europe is expected to grow from US$ 22.55 million in 2021 to US$ 39.26 million by 2028; it is estimated to grow at a CAGR of 8.2% from 2021 to 2028.

Blood transfusion is an integral part of the national health infrastructure and policies of various countries. Advancements in the medical industry have led to improvements in the treatment procedures of serious illnesses and injuries, which eventually has propelled the need for blood transfusion for patients’ survival. Growing awareness regarding the importance of blood transfusion and blood availability in healthcare services has led to rise in the number of people willing to donate their blood for medical causes. As per the World Health Organization (WHO) data, ~117.4 million blood donations were reported worldwide in 2018. Blood donors are usually classified to be voluntary unpaid, paid, and family/replacement, and as per the WHO claims, voluntary/unpaid donors are the major source of a reliable and adequate supply of blood. According to WHO data in 2019, blood donations by voluntary unpaid donors increased by 11.6 million from 2008 to 2015 in 139 countries in the world. The trend of blood donation is also gaining significant prominence in low and middle-income countries. According to the data presented during the CAG annual meeting 2017, ~13,000 procedures were performed on 1,087 patients in 2016. National programs developed and rolled out in many countries are further attracting a large number of platelet and blood donors. Thus, the rising number of eligible donors in different countries across the world is fostering the need for leukapheresis equipment that is used to separate the required blood components.

The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Russia, Spain, Italy, Germany, France, and the UK are among the most affected European countries. Countries across Europe are witnessing a resurgence in COVID-19 cases after successfully mitigating outbreaks early in the year. Many countries are declaring more cases each day now than they were during the first wave earlier this year. Lockdowns are being reintroduced in UK, Spain, Italy, and Ireland, as per the European Centre for Disease Prevention and Control (ECDC). Due to the second wave of COVID-19 cases, the government of many countries is working towards scaling up testing capacity, which is driving the growth of the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe leukapheresis market. The Europe leukapheresis market is expected to grow at a good CAGR during the forecast period.

Europe leukapheresis market

Get more information on this report :


Europe Leukapheresis Market Segmentation

Europe Leukapheresis Market – By Product Type

  • Leukapheresis Disposables
  • Leukapheresis Devices

Europe Leukapheresis Market – By Application

  • Research Applications
  • Therapeutic Applications

Europe Leukapheresis Market – By Product Type

  • Blood Component Providers and Blood Centers
  • Hospitals and Transfusion Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes

Europe Leukapheresis Market – By Country

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Europe Leukapheresis Market – Companies Mentioned

  • Asahi Kasei Corporation
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • HemaCare
  • Macopharma
  • AllCells
  • STEMEXPRESS
  • BioIVT

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Leukapheresis Market – By Product Type

1.3.2 Europe Leukapheresis Market – By Application

1.3.3 Europe Leukapheresis Market – By End User

1.3.4 Europe Leukapheresis Market – By Country

2. Europe Leukapheresis Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Leukapheresis Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinions

5. Europe Leukapheresis Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Elevating Number of Voluntary Blood Donors

5.1.2 Growing Incidence of Hematologic Diseases

5.1.3 Scaling Elderly Population

5.2 Key Market Restraints

5.2.1 Heavy Cost of Leukapheresis

5.3 Key Market Opportunities

5.3.1 Boosting Opportunities in Emerging Economies

5.4 Future Trends

5.4.1 Advancements in Therapeutic Apheresis

5.5 Impact Analysis

6. Europe Leukapheresis – Market Analysis

6.1 Europe Leukapheresis Market Revenue Forecast and Analysis

7. Europe Leukapheresis Market Analysis – by Product Type

7.1 Overview

7.2 Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3 Leukapheresis Devices

7.3.1 Overview

7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1 Apheresis Devices

7.3.2.1.1 Overview

7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2 Leukapheresis ColuMillions and Cell Separators

7.3.2.2.1 Overview

7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3 Leukoreduction Filters

7.3.2.3.1 Overview

7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)

7.4 Leukapheresis Disposables

7.4.1 Overview

7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)

8. Europe Leukapheresis Market Analysis – by Application

8.1 Overview

8.2 Europe Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3 Research Applications

8.3.1 Overview

8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)

8.4 Therapeutic Applications

8.4.1 Overview

8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)

9. Europe Leukapheresis Market Analysis – by End-User

9.1 Overview

9.2 Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)

9.3 Pharmaceutical and Biotechnology Companies

9.3.1 Overview

9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)

9.4 Blood Component Providers and Blood Centers

9.4.1 Overview

9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)

9.5 Academic and Research Institutes

9.5.1 Overview

9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.6 Hospitals and Transfusion Centers

9.6.1 Overview

9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)

10. Europe Leukapheresis Market – Country Analysis

10.1 Overview

10.1.1 Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.1.1 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 Overview

10.1.1.1.2 Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 Germany: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.1.3.1 Germany: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.1.4 Germany: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.1.5 Germany: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.2 France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 France: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.2.1.1 France: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.2.2 France: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.2.3 France: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.3 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 Overview

10.1.1.3.2 UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 UK: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.3.3.1 UK: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.3.4 UK: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.3.5 UK: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.4 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1 Overview

10.1.1.4.2 Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3 Italy: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.4.3.1 Italy: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.4.4 Italy: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.4.5 Italy : Leukapheresis Market, by End User, 2019-2028 (USD Million)

10.1.1.5 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1 Overview

10.1.1.5.2 Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3 Spain: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.5.3.1 Spain: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.5.4 Spain: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.5.5 Spain: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.6 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3 Rest of Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.6.3.1 Rest of Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.6.4 Rest of Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.6.5 Rest of Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)

11. Europe Leukapheresis Market – Impact of COVID-19 Pandemic

11.1 Impact Assessment Of COVID-19 Pandemic

12. Europe Leukapheresis Market – Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Asahi Kasei Corporation

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Fresenius SE & Co. KGaA

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Haemonetics Corporation

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Terumo Corporation

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 STEMCELL Technologies Inc.

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 HemaCare

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Macopharma

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 AllCells

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 STEMEXPRESS

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 BioIVT

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About the Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany Leukapheresis Market, by D Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. Germany: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5. France: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 6. France Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7. France Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8. France: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9. UK: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 10. UK Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11. UK Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12. UK: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13. Italy: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 14. Italy Leukapheresis Market, by Leukapheresis Devices– Revenue and Forecast to 2028 (USD Million)

Table 15. Italy Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Italy: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17. Spain: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 18. Spain Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 19. Spain Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20. Spain: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21. Rest of Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of Europe: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25. Organic Developments Done by Companies

Table 26. Inorganic Developments Done by Companies

Table 27. Glossary of Terms, Leukapheresis Market

LIST OF FIGURES

Figure 1. Europe Leukapheresis Market Segmentation

Figure 2. Europe Leukapheresis Market Segmentation, By country

Figure 3. Europe Leukapheresis Market Overview

Figure 4. Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5. Germany to Show Significant Growth During Forecast Period

Figure 6. Europe Leukapheresis Market, Industry Landscape

Figure 7. Europe PEST Analysis

Figure 8. Europe Leukapheresis market impact analysis of driver and restraints

Figure 9. Europe Leukapheresis Market – Revenue Forecast and Analysis (2021- 2028)

Figure 10. Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Europe Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)

Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. Europe: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 25. Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 26. Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 27. France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Impact of COVID-19 Pandemic in European Country Markets

  1. Asahi Kasei Corporation                                 
  2. Fresenius SE & Co. KGaA                                
  3. Haemonetics Corporation                              
  4. Terumo Corporation                                        
  5. STEMCELL Technologies Inc.                          
  6. HemaCare  
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS  
  10. BioIVT 
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe leukapheresis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution  
TIPRE00025790
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.